However, there is a notable difference in the amount of research using GHK-Cu topical vs injection delivery methods
Disease-focused reviews have systematically summarized how nanoparticle drug delivery systems have been applied to specific tumor entities, such as triple-negative breast cancer, highlighting improvements in pharmacokinetics, tumor accumulation and targeting specificity, while also underscoring persistent challenges related to intratumoral heterogeneity and limited penetration [22]
It also connects to 60 chronic health conditions, including Hashimotos and hypothyroidism, blood clots, infertility, cardiovascular disease, Alzheimers, depression, birth defects, and certain cancers
GLOW targets dermal structure
In mitochondria the major sources of ROS include OXPHOS complexes I and III, and the dehydrogenases that use ubiquinone as an acceptor, and this includes succinate dehydrogenase (OXPHOS complex II)
This supports healthy detoxification processes, optimal liver function, and balanced immune activity
